Reprint

A Feasible Approach for Natural Products to Treatment of Diseases

Edited by
June 2023
260 pages
  • ISBN978-3-0365-7873-6 (Hardback)
  • ISBN978-3-0365-7872-9 (PDF)

This book is a reprint of the Special Issue A Feasible Approach for Natural Products to Treatment of Diseases that was published in

Chemistry & Materials Science
Medicine & Pharmacology
Summary

Introducing “A Feasible Approach for Natural Products to Treatment of Diseases”–an exploration of the therapeutic potential locked within nature’s abundant offerings. This comprehensive reprint delves into the fascinating realm of natural products, uncovering their inherent properties, mechanisms of action, and potential roles in effective disease management. Through extensive scientific research and reviews, the authors shed light on the immense potential of natural products as a viable approach to enhancing health and combating diseases. This reprint presents a diverse and multidimensional exploration, bridging the gap between traditional wisdom and contemporary scientific understanding and offering new avenues for healthcare professionals, researchers, and enthusiasts to harness the power of nature’s remarkable resources. As a catalyst for unlocking the healing potential of natural products, this reprint inspires further investigation and innovation, and drives us towards a future where their integration into mainstream healthcare becomes indispensable. Discover the possibilities and embark on a health and well-being journey with “A Feasible Approach for Natural Products to Treatment of Diseases”.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
cancer immunotherapy; fructan; FT-IR; mass spectrometry; young green barley; COVID-19; β-glucans; immunomodulation; anti-inflammation; anti-oxidant; ACE2 regulation; impedance; ECIS; antitumor activity; anticancer properties; betulin; betulinic acid; Amadori rearrangement compounds; barley; anti-obesity; arginyl-fructose; adipogenic; ergosta-5,7,22,24(28)-tetraenol (ERGT); cholesta-5,7,22,24-tetraenol (CHT); ergosterol biosynthesis; antimetabolite; suicide substrate; Trypanosoma brucei; coronavirus SARS-CoV-2; COVID-19; main protease; Saussurea costus; molecular docking; GC-MS profiling; Molineria recurvata; diabetic nephropathy; urinary biomarkers; inflammation; oxidative stress; walnut; Juglans regia; high-fat diet; insulin resistance; inflammation; cognitive function; JNK/NFκB pathway; Citri Reticulatae Pericarpium; flavonoids; anticancer; mechanism; phenotype; Angelica sinensis polysaccharide; Astragalus membranaceus polysaccharide; hexokinase 2; glycolysis; JAK2/STAT3 pathway; liver regeneration; Holoptelea integrifolia; MMP-9; anti-inflammation; wound healing; friedelin; oxalactam A; macrolactam; anti-Rhizoctonia solani; Penicillium oxalicum; molecular docking; molecular dynamics; non-alcoholic fatty liver disease (NAFLD); natural products; terpenoids; mechanisms; treatment; n/a